US Patent Issued to Fred Hutchinson Cancer Center on March 31 for "Systems to produce B cells genetically modified to express selected antibodies" (Washington Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,145, issued on March 31, was assigned to Fred Hutchinson Cancer Center (Seattle).

"Systems to produce B cells genetically modified to express selected antibodies" was invented by Justin J. Taylor (Seattle) and Howell F. Moffett (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods to genetically modify B cells to express selected antibodies are described. The systems and methods can be used to: obviate the need for classical vaccinations; provide protection against infectious agents for which no vaccinations are currently available; provide protection against infectious agents when patients are otherwise immune-suppressed; and...